Diagnosing SI Joint Disorders: SI Joint Injection Demonstration

To speak with a nurse or find a surgeon, call 888-689-5277 or visit

Learn more about the sacroiliac joint in

The current standard is that the injection of the sacroiliac joint should be performed under fluoroscopic guidance, using contrast to confirm the placement of the needle, injecting no more than 2 cc. of solution if it is a diagnostic and / or therapeutic injection.

The percentage of pain reduction that we seek after performing a diagnostic injection of pain in the sacroiliac joint by fluoroscopy is a pain reduction greater than or equal to 75% when comparing preoperative and postoperative visual analog pain scores in 15 to 30 minutes .

We use provocative maneuvers or simple functional activities such as sitting, standing and walking as typical measures of pain reduction. In addition, patients will take home a pain diary where they will record their pain intensity scores every two hours for up to 24 hours.

After a therapeutic injection of the sacroiliac joint is performed, the next step in the treatment plan is a pelvic strengthening and stabilization program. This program usually lasts six to eight weeks.

When patients do not respond to therapeutic injections of the sacroiliac joint along with physical rehabilitation treatment, the next step in the treatment plan would be to consider a minimally invasive fusion of the sacroiliac joint.

Amish Patel, DO – paid consultant of SI-BONE

The iFuse implant system is designed for sacroiliac fusion in conditions that include sacroiliac joint dysfunction that is a direct result of disruption of the sacroiliac joint and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted after delivery for more than 6 months.

There are potential risks associated with the iFuse implant system. It may not be appropriate for all patients and all patients may not benefit. For risk information, visit: www.si-bone.com/risks

U.S. Patent Nos. 8,202,305; 8,840,623; 8,986,348; and 9,039,743; pending US patent applications UU and foreign

(C) 2012. SI-BONE, Inc. All rights reserved. SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc.

Video credits to SI-BONE iFuse YouTube channel

  • Your reaction?
    Angry Angry
    Lol Lol
    Love It! Love It!
    Love It!
    Nice Nice
    Now I Know Now I Know
    Now I Know
    Sad Sad
    Surprised Surprised
    Wow! Wow!

    Diagnosing SI Joint Disorders: SI Joint Injection Demonstration

    log in

    reset password

    Back to
    log in